Syneos Health, Inc.
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinic…
Medical - Diagnostics & Research
US, Morrisville [HQ]
Ratios
12 Records · Starting from 2011Margins, Growth Rates In %
| Ratio | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||
| Gross Margin | 23.96 | 21.88 | 22.12 | 25.00 | 26.61 | 25.07 | 23.23 | 21.77 | 22.03 | 23.05 | 23.37 | 23.26 | |
| Profit Margin | -9.08 | -6.81 | -4.17 | -1.99 | 8.37 | 6.99 | -5.18 | 0.55 | 2.81 | 4.37 | 4.50 | 4.94 | |
| Operating Margin | -6.13 | -4.32 | 3.16 | 5.40 | 10.89 | 9.65 | -1.08 | 3.65 | 6.94 | 6.64 | 7.47 | 7.48 | |
|
EPS Growth
|
- - | 0.87 | 29.83 | 45.00 | 559.09 | 2.97 | -188.94 | 112.43 | 452.17 | 45.67 | 22.16 | 13.72 | |
| EPS USD | -115.00 | -114.00 | -80.00 | -44.00 | 202.00 | 208.00 | -185.00 | 23.00 | 127.00 | 185.00 | 226.00 | 257.00 | |
| Return on Assets (ROA) | - - | -4.70 | -3.37 | -1.89 | 9.66 | 8.74 | -1.90 | 0.33 | 1.76 | 2.39 | 2.85 | 3.25 | |
| Return on Equity (ROE) | - - | -18.66 | -15.04 | -5.98 | 53.83 | 37.36 | -4.58 | 0.85 | 4.33 | 5.95 | 6.88 | 7.63 | |
| Return on Invested Capital (ROIC) | - - | -2.55 | 4.88 | 6.52 | 18.93 | 16.32 | -0.59 | 1.19 | 6.69 | 4.10 | 4.27 | 5.11 | |
| Solvency | |||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | - - | 47.25 | 48.21 | 33.73 | 41.43 | 38.63 | 41.28 | 38.98 | 39.17 | 39.87 | 37.38 | 35.36 | |
| Debt/Equity | - - | 187.54 | 215.23 | 107.08 | 230.80 | 165.10 | 99.51 | 99.00 | 96.37 | 99.16 | 90.24 | 82.94 | |
| Debt/EBITDA | - - | 608.20 | 486.85 | 196.26 | 191.08 | 180.16 | 840.74 | 459.51 | 486.05 | 509.01 | 452.94 | 398.13 | |
|
Debt/Capitalization
|
- - | 65.22 | 68.28 | 51.71 | 69.77 | 62.28 | 49.88 | 49.75 | 49.08 | 49.79 | 47.43 | 45.34 | |
| Long-Term Debt/Capitalization | - - | 65.00 | 68.02 | 51.43 | 68.46 | 61.71 | 49.53 | 49.18 | 48.08 | 49.32 | 46.91 | 44.75 | |
| Interest Debt per Share USD | - - | 12.65 | 12.60 | 8.87 | 8.94 | 9.43 | 41.00 | 28.26 | 29.04 | 31.34 | 30.06 | 28.80 | |
| Debt Growth | - - | - - | 0.05 | -29.35 | 19.49 | -0.82 | 504.30 | -5.99 | 3.25 | 10.11 | -4.21 | -5.86 | |
| Liquidity | |||||||||||||
| Current Ratio | - - | 114.21 | 118.29 | 112.40 | 88.93 | 111.98 | 122.65 | 99.25 | 103.01 | 110.19 | 106.79 | 112.71 | |
| Quick Ratio | - - | 99.47 | 102.45 | 98.69 | 80.71 | 104.52 | 115.32 | 93.98 | 96.76 | 102.51 | 98.62 | 101.88 | |
| Cash Ratio | - - | 26.22 | 30.49 | 33.29 | 17.91 | 21.96 | 27.71 | 10.37 | 10.79 | 17.26 | 6.44 | 6.49 | |
| Operating Cash Flow Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | |||||||||||||
| Inventory Turnover | - - | 6,758.75 | 5,184.54 | 5,299.90 | 227,190.93 | 198,829.00 | 287,289.08 | - - | - - | - - | - - | - - | |
| Receivables Turnover | - - | 382.20 | 434.85 | 474.61 | 469.52 | 417.96 | 263.00 | 349.33 | 358.67 | 328.36 | 341.86 | 327.82 | |
| Payables Turnover | - - | 3,959.10 | 8,077.27 | 5,342.82 | 4,564.62 | 5,093.88 | 3,501.91 | 3,482.23 | 2,667.36 | 2,989.11 | 3,714.59 | 3,489.11 | |
|
Asset Turnover
|
- - | 69.07 | 80.70 | 94.68 | 115.52 | 125.00 | 36.67 | 60.51 | 62.73 | 54.76 | 63.29 | 65.78 | |
| Fixed Turnover | - - | 2,058.49 | 2,430.19 | 2,695.94 | 3,122.40 | 2,762.32 | 1,481.09 | 2,392.62 | 1,106.81 | 1,004.76 | 1,206.52 | 1,233.86 | |
| Coverage | |||||||||||||
| Interest Coverage | -61.24 | -60.29 | 51.74 | 120.00 | 974.17 | 1,292.93 | -45.30 | 122.56 | 250.00 | 322.56 | 491.88 | 499.07 | |
| Asset Coverage | - - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 200 | |
| Cash Flow Coverage (CFGR) | - - | 7.24 | 6.27 | 31.30 | 40.80 | 21.97 | 6.59 | 10.73 | 10.91 | 13.24 | 14.62 | 14.73 | |
| EBITDA Coverage | - - | 100 | 100 | 200 | 1,300 | 1,800 | 500 | 400 | 400 | 600 | 800 | 800 | |
| Dividend Coverage | 1,300 | 11,800 | 8,300 | 6,200 | - - | - - | - - | - - | - - | - - | - - | - - | |
| Time Interest Earned (TIE) | - - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |
| Market Prospects | |||||||||||||
| Dividend Yield | 0.42 | 0.05 | 0.05 | 0.03 | - - | - - | - - | - - | - - | - - | - - | - - | |
| Earnings Yield | -5.60 | -5.56 | -3.90 | -1.71 | 4.17 | 3.96 | -4.24 | 0.59 | 2.10 | 2.68 | 2.18 | 7.02 | |
|
Price/Earnings (P/E)
|
-17.8587 | -17.9895 | -25.6607 | -58.3427 | 23.9916 | 25.2333 | -23.5880 | 169.6584 | 47.5754 | 37.2708 | 45.9397 | 14.2423 | |
| Price/Earnings Growth (PEG) | - - | 2,068.79 | 86.04 | 129.65 | -4.29 | 849.52 | 12.48 | -150.90 | 10.52 | 81.61 | 207.29 | 103.83 | |
|
Price/Book (P/B)
|
- - | 335.65 | 385.82 | 349.13 | 1,291.49 | 942.71 | 108.06 | 144.25 | 206.12 | 221.62 | 316.13 | 108.60 | |
| Price/Tangible Book (P/TB) | - - | 335.65 | 385.82 | 349.13 | 1,291.49 | 942.71 | 108.06 | 144.25 | 206.12 | 221.62 | 316.13 | 108.60 | |
| Price/Sales (P/S) | 162.11 | 122.43 | 107.09 | 116.16 | 200.69 | 176.46 | 122.24 | 93.85 | 133.55 | 162.72 | 206.95 | 70.38 | |
|
Price/Cash Flow (P/CF)
|
-5,738.04 | 2,473.15 | 2,859.31 | 1,041.71 | 1,371.57 | 2,599.45 | 1,647.45 | 1,357.72 | 1,960.76 | 1,688.71 | 2,395.87 | 888.92 | |
| Price/Free CF (P/FCF) | -4,564.87 | 3,183.16 | 5,449.30 | 1,293.06 | 1,529.25 | 3,644.61 | 2,115.94 | 1,655.59 | 2,453.62 | 1,913.62 | 2,742.01 | 1,138.02 | |
| Price/Operating CF (P/OCF) | -5,738.04 | 2,473.15 | 2,859.31 | 1,041.71 | 1,371.57 | 2,599.45 | 1,647.45 | 1,357.72 | 1,960.76 | 1,688.71 | 2,395.87 | 888.92 |